Cargando…
Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies
BACKGROUND AND AIM: The world of work has been profoundly affected by the COVID-19 pandemic since workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2 and compromise continuity of operations of workplaces.The Covid-Lab of University of Urbi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851024/ https://www.ncbi.nlm.nih.gov/pubmed/34739463 http://dx.doi.org/10.23750/abm.v92iS6.12238 |
_version_ | 1784652740989812736 |
---|---|
author | Orlandi, Chiara Schiavano, Giuditta Fiorella Brandi, Giorgio Magnani, Mauro Casabianca, Anna |
author_facet | Orlandi, Chiara Schiavano, Giuditta Fiorella Brandi, Giorgio Magnani, Mauro Casabianca, Anna |
author_sort | Orlandi, Chiara |
collection | PubMed |
description | BACKGROUND AND AIM: The world of work has been profoundly affected by the COVID-19 pandemic since workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2 and compromise continuity of operations of workplaces.The Covid-Lab of University of Urbino and the Confindustria Pesaro Urbino association signed an agreement to support the Marche Nord companies in the adoption of anti-contagion safety protocols. METHODS: Antibodies detection was performed using a rapid immunochromatographic test. Total RNA from nasopharyngeal swab was subjected to a real-time RT-PCR multiplex for the detection of RdRp specific gene and E gene of the SARS-CoV-2, and the internal control (human RNase P). RESULTS: Between May 2020 and Apr 2021, over 10,000 rapid serological tests had been carried out on workers of 35 companies and in 5% of cases IgG or IgM were found (519). All the 519 swabs gave a valid result (RNAse P Ct≤40) with 105 positive results (20%) for SARS-CoV-2 with a Ct value ≤45. Overall, only 1% of samples resulted positive for viral RNA (105/10000). CONCLUSIONS: The University of Urbino set up a rapid-response (within 24 h, generally <6 h) diagnostic centre for SARS-CoV-2 detection (Covid-Lab) allowing the companies to activate the optimal safety path to ensure the health and safety of workers in the workplace. Our observations during this first year of activity, highlight that in the workplace, the infection does not seem to spread if precautionary measures are followed and only 1% (1 worker out of 100) tested positive for the SARS-CoV-2 virus. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-8851024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-88510242022-02-28 Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies Orlandi, Chiara Schiavano, Giuditta Fiorella Brandi, Giorgio Magnani, Mauro Casabianca, Anna Acta Biomed Original Investigations/Commentaries BACKGROUND AND AIM: The world of work has been profoundly affected by the COVID-19 pandemic since workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2 and compromise continuity of operations of workplaces.The Covid-Lab of University of Urbino and the Confindustria Pesaro Urbino association signed an agreement to support the Marche Nord companies in the adoption of anti-contagion safety protocols. METHODS: Antibodies detection was performed using a rapid immunochromatographic test. Total RNA from nasopharyngeal swab was subjected to a real-time RT-PCR multiplex for the detection of RdRp specific gene and E gene of the SARS-CoV-2, and the internal control (human RNase P). RESULTS: Between May 2020 and Apr 2021, over 10,000 rapid serological tests had been carried out on workers of 35 companies and in 5% of cases IgG or IgM were found (519). All the 519 swabs gave a valid result (RNAse P Ct≤40) with 105 positive results (20%) for SARS-CoV-2 with a Ct value ≤45. Overall, only 1% of samples resulted positive for viral RNA (105/10000). CONCLUSIONS: The University of Urbino set up a rapid-response (within 24 h, generally <6 h) diagnostic centre for SARS-CoV-2 detection (Covid-Lab) allowing the companies to activate the optimal safety path to ensure the health and safety of workers in the workplace. Our observations during this first year of activity, highlight that in the workplace, the infection does not seem to spread if precautionary measures are followed and only 1% (1 worker out of 100) tested positive for the SARS-CoV-2 virus. (www.actabiomedica.it) Mattioli 1885 2021 2021-10-01 /pmc/articles/PMC8851024/ /pubmed/34739463 http://dx.doi.org/10.23750/abm.v92iS6.12238 Text en Copyright: © 2021 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Investigations/Commentaries Orlandi, Chiara Schiavano, Giuditta Fiorella Brandi, Giorgio Magnani, Mauro Casabianca, Anna Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies |
title | Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies |
title_full | Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies |
title_fullStr | Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies |
title_full_unstemmed | Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies |
title_short | Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies |
title_sort | prevalence of sars-cov-2 infection in the workplace: results of a year of investigation in the marche nord companies |
topic | Original Investigations/Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851024/ https://www.ncbi.nlm.nih.gov/pubmed/34739463 http://dx.doi.org/10.23750/abm.v92iS6.12238 |
work_keys_str_mv | AT orlandichiara prevalenceofsarscov2infectionintheworkplaceresultsofayearofinvestigationinthemarchenordcompanies AT schiavanogiudittafiorella prevalenceofsarscov2infectionintheworkplaceresultsofayearofinvestigationinthemarchenordcompanies AT brandigiorgio prevalenceofsarscov2infectionintheworkplaceresultsofayearofinvestigationinthemarchenordcompanies AT magnanimauro prevalenceofsarscov2infectionintheworkplaceresultsofayearofinvestigationinthemarchenordcompanies AT casabiancaanna prevalenceofsarscov2infectionintheworkplaceresultsofayearofinvestigationinthemarchenordcompanies |